Category: ROOT

City of Hope rating downgraded amid debt and operating weakness

Duarte, Calif.-based City of Hope has been downgraded from “A+” to “A” as the health system struggles with declining operating performance and increased debt linked to its acquisition of Cancer Treatment Centers of America, S&P Global Ratings said Dec….

Physician group backs controversial Texas hospital

Physician-Led Healthcare for America said the expansion of a physician-owned hospital near the Texas-Mexico border is a “win” for patients.

COVID-19 admissions flatten: What CDC predicts for January

COVID-19 hospitalizations appear to be leveling off in the U.S. after a steady month of growth, though it’s still unclear how the holiday season may affect this trend.

Files may have been stolen from Arkansas hospital during cyberattack

Nashville, Ark.-based Howard Memorial Hospital reported hackers may have stolen files from its network during a cyberattack earlier this year.

University Hospitals eyes unified Epic EHR in 2023

University Hospitals in Cleveland aims to have a unified EHR platform by the end of 2023.

Plastic surgery group sued for fake positive online reviews, forced removal of negative comments

Washington’s attorney general is suing Seattle-based Allure Esthetic and its owner Javad Sajan, MD, alleging that patients were illegally coerced to remove negative reviews and staff were forced to post fake positive reviews online, The Seattle Times r…

South Carolina physicians win approval for ASC

A general surgeon and radiologist are now able to build a private ASC in Orangeburg, S.C., The Times and Democrat reported Dec. 29.

AmerisourceBergen sued again for alleged opioid violations

The Justice Department sued drug distributor AmerisourceBergen, one of the largest in the nation, over allegedly failing to flag suspicious orders for opioids and other controlled substances, according to a Dec. 29 news release.

Federal investigation blames FDA, Biogen for Aduhelm scandal

Murky documentation of meetings between Biogen and the FDA, plus an “unjustifiably high price” for a drug that lacked clinical data, are at fault for the Adulelm controversy, two House committees said Dec. 29 in a report. 

He was the hospital's financial auditor. Now he's its CEO.

When Brian Barta walks into a room, the first thing he does is start asking questions.